TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6487462

Group type: EXPERIMENTAL
Intervention: Cyclosidimine 2.5 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cyclosidimine 5.0 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cyclosidimine 7.5 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 5
Study: 29599038

Group type: EXPERIMENTAL
Intervention: Opioid-related preoperative education
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no opioid-related preoperative education)
Number of subjects: 140
Study: 26653112

Group type: EXPERIMENTAL
Intervention: 4000 IU daily vitamin D3
Number of subjects: 38

Group type: COMPARATOR
Intervention: 400 IU daily vitamin D3
Number of subjects: 38
Study: 25347898

Group type: EXPERIMENTAL
Intervention: Miltefosine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meglumine antimoniate (conventional chemotherapy)
Number of subjects: 0
Study: 22925288

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH) solution (0.2% two-fold diluted MucoUp)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 94
Study: 20818887

Group type: EXPERIMENTAL
Intervention: Ecallantide (30 mg subcutaneous)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 18477422

Group type: EXPERIMENTAL
Intervention: Micafungin (MICA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liposomal amphotericin B (L‐AMB)
Number of subjects: 0
Study: 15807739

Group type: EXPERIMENTAL
Intervention: Isotretinoin (1 mg/kg/day) + Vitamin E (800 IU/day)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Isotretinoin (1 mg/kg/day)
Number of subjects: 82
Study: 14556129

Group type: EXPERIMENTAL
Intervention: 25 microg epinephrine with 1.5% lidocaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 microg epinephrine with 1.5% lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1.5% lidocaine alone
Number of subjects: 60
Study: 12370843

Group type: EXPERIMENTAL
Intervention: Camelina oil
Number of subjects: 68

Group type: COMPARATOR
Intervention: Rapeseed oil
Number of subjects: 68

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 68
Study: 10426708

Group type: EXPERIMENTAL
Intervention: Nonsupplemented formula
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Formula-fed infants
Number of subjects: 83

Group type: COMPARATOR
Intervention: Breast milk
Number of subjects: 83
Study: 7485885

Group type: EXPERIMENTAL
Intervention: Rectal diclofenac 100 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous ketorolac 10 mg
Number of subjects: 40
Study: 2181312

Group type: EXPERIMENTAL
Intervention: Low dose ivermectin (21.3 +/- 0.7 micrograms per kilogram; n = 13)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High dose ivermectin (126.2 +/- 3.7 micrograms per kilogram; n = 13)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diethylcarbamazine (6 mg per kilogram per day for 12 days preceded by 3 mg per kilogram for 1 day; n = 14)
Number of subjects: 40
Study: 7029369

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 31624364

Group type: EXPERIMENTAL
Intervention: Hematologic biomarkers (Hemoglobin)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Hematologic biomarkers (Hepcidin)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Hepcidin cutoff <4.3 µg/L
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Baseline hemoglobin >110 g/L
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Baseline hepcidin >1.6 µg/L
Number of subjects: 2100
Study: 31120390

Group type: EXPERIMENTAL
Intervention: Early morphosyntactic knowledge
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Early comprehension of relational terms
Number of subjects: 714
Study: 28108117

Group type: EXPERIMENTAL
Intervention: Insecticidal bait
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control homes
Number of subjects: 102
Study: 26425700

Group type: EXPERIMENTAL
Intervention: Plasma DNA methylation profiles
Number of subjects: 204
Study: 23305245

Group type: EXPERIMENTAL
Intervention: Trimethoprim 200 mg twice daily from day 5 to 10
Number of subjects: 24
Study: 21557754

Group type: EXPERIMENTAL
Intervention: Tandy™ (959 ppm F, tutti-frutti-flavored)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Sorriso™ (1219 ppm F, peppermint-flavored)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 0.3 g of dentifrice
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 1.2 g of dentifrice
Number of subjects: 155
Study: 18461392

Group type: EXPERIMENTAL
Intervention: Intradermal injection of 0.1 ml 1% acetylcholine in group A
Number of subjects: 30

Group type: COMPARATOR
Intervention: Surgery in group B (1999-2001)
Number of subjects: 30
Study: 17519054

Group type: EXPERIMENTAL
Intervention: Videoconferencing
Number of subjects: 113
Study: 15167456

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 2334

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 2334
Study: 11282810

Group type: EXPERIMENTAL
Intervention: 20 mg of paroxetine
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Gradual reduction of diazepam
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Total group
Number of subjects: 230
Study: 9754775

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg plus Amoxicillin 1000 mg b.i.d (OA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Omeprazole 20 mg and Placebo b.i.d (OP)
Number of subjects: 28
Study: 7826832

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) - total dose of 1500 mg given over 3 days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Desethylchloroquine (DECQ)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: DECQ to CQ ratio
Number of subjects: 14
Study: 2900013

Group type: EXPERIMENTAL
Intervention: Betaxolol (2 months)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Atenolol (2 months)
Number of subjects: 21
Study: 29446268

Group type: EXPERIMENTAL
Intervention: Customized trays (TB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Strips (SB)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Trays (TB)
Number of subjects: 50
Study: 27561870

Group type: EXPERIMENTAL
Intervention: Tobacco Tactics Web‐based intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: 1‐800‐QUIT‐NOW telephone line
Number of subjects: 41
Study: 24966150

Group type: EXPERIMENTAL
Intervention: Propofol-epidural anaesthesia (PEA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 40
Study: 22882208

Group type: EXPERIMENTAL
Intervention: 5 applications of 0.15-mm microneedles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 applications of 0.25-mm microneedles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 applications of 0.15-mm microneedles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 applications of 0.25-mm microneedles
Number of subjects: 0
Study: 21235066

Group type: COMPARATOR
Intervention: EA-proximal acupoints group (EA-PA group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: EA-distant acupoints group (EA-DA group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: General anesthesia (GA) group
Number of subjects: 120
Study: 18454214

Group type: EXPERIMENTAL
Intervention: 10 mg.kg-1 ketamine 5%
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2.5% ketamine
Number of subjects: 100
Study: 16418156

Group type: EXPERIMENTAL
Intervention: Nerve gliding exercises combined with conservative treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Static volar wrist splints and conservative treatment
Number of subjects: 26
Study: 14736584

Group type: EXPERIMENTAL
Intervention: Observer present (n=34)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Participant alone (n=30)
Number of subjects: 64
Study: 11127075

Group type: EXPERIMENTAL
Intervention: Educational outreach visit (20 minutes)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Unrelated topic intervention (control group)
Number of subjects: 157
Study: 9369411

Group type: EXPERIMENTAL
Intervention: Urate oxidase (Uricozyme)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 134
Study: 1607432

Group type: EXPERIMENTAL
Intervention: Chewable preparation containing chlorhexidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xylitol control tablets
Number of subjects: 0
Study: 3984878

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase (STK)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase (STK) in patients with reperfusion
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no treatment) in patients with reperfusion
Number of subjects: 44
Study: 2451713

Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy followed by definitive treatment (arm A)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Alternating chemotherapy and radiotherapy (arm B)
Number of subjects: 116
Study: 31092666

Group type: EXPERIMENTAL
Intervention: Prehabilitation (structured exercise training, aerobic and resistance) supervised by a physiotherapist, 2 sessions/week for 6-10 weeks before surgery.
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard care (no prehabilitation).
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Prehabilitation (structured exercise training).
Number of subjects: 164
Study: 28768654

Group type: EXPERIMENTAL
Intervention: High-fat diet (40-45% fat, 15% protein, 40-45% carbohydrate)
Number of subjects: 757

Group type: COMPARATOR
Intervention: Low-fat diet (20-25% fat, 15% protein, 60-65% carbohydrate)
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 757
Study: 24584605

Group type: EXPERIMENTAL
Intervention: MgCaCO3 (100 mg calcium, 85 mg magnesium per tablet)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CaCO3 (200 mg calcium per tablet)
Number of subjects: 20
Study: 24379009

Group type: EXPERIMENTAL
Intervention: Beef lunch (3-oz, 3 times weekly for 16 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-beef lunch (3-oz, 3 times weekly for 16 weeks)
Number of subjects: 43
Study: 21257028

Group type: EXPERIMENTAL
Intervention: Malleable protein matrix (MPM) 2 × 15 g/d
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 18790543

Group type: EXPERIMENTAL
Intervention: Sulfotanshinone Sodium Injection (SSI) 60 mg combined with a loading dose of 300 mg aspirin and a maintenance dose of 100 mg of aspirin plus baseline therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspirin (300 mg loading dose and 100 mg maintenance dose) plus baseline therapy
Number of subjects: 100
Study: 16446121

Group type: EXPERIMENTAL
Intervention: Pregabalin as add-on therapy
Number of subjects: 5
Study: 12232545

Group type: EXPERIMENTAL
Intervention: Agomelatine 5 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Agomelatine 100 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both doses of agomelatine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (placebo run-in)
Number of subjects: 28
Study: 9950657

Group type: EXPERIMENTAL
Intervention: Activated protein C (APC) response
Number of subjects: 826
Study: 7761292

Group type: EXPERIMENTAL
Intervention: Combination of behavior modification and mutual goal setting
Number of subjects: 79

Group type: COMPARATOR
Intervention: Mutual goal setting only
Number of subjects: 79

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 79
Study: 2175584

Group type: EXPERIMENTAL
Intervention: 4 mg perindopril
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 8 mg perindopril
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 16 mg perindopril
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 373990

Group type: EXPERIMENTAL
Intervention: Haloperidol 0.5 mg twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam 2 mg three times daily
Number of subjects: 60
Study: 31381147

Group type: EXPERIMENTAL
Intervention: Nintedanib 200 mg twice daily on days 2‐21 every 3 weeks for up to 120 weeks combined with carboplatin and paclitaxel.
Number of subjects: 1366

Group type: COMPARATOR
Intervention: Placebo combined with carboplatin and paclitaxel.
Number of subjects: 1366
Study: 29298726

Group type: EXPERIMENTAL
Intervention: BMAC-PRP injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rotator cuff exercise
Number of subjects: 24
Study: 27421729

Group type: EXPERIMENTAL
Intervention: Diet + 42 KKW moderate intensity
Number of subjects: 237

Group type: COMPARATOR
Intervention: High amount (67 KKW)/moderate intensity
Number of subjects: 237

Group type: COMPARATOR
Intervention: High amount (67 KKW)/vigorous intensity
Number of subjects: 237

Group type: COMPARATOR
Intervention: Low amount (42 KKW)/moderate intensity
Number of subjects: 237
Study: 25394847

Group type: EXPERIMENTAL
Intervention: Di'ao Xin Xue Kang (XXK) capsule
Number of subjects: 733

Group type: COMPARATOR
Intervention: Compound Danshen (CDS) tablet
Number of subjects: 733
Study: 22842953

Group type: EXPERIMENTAL
Intervention: Topical capsaicin 0.075 % 3 times daily for 6 weeks
Number of subjects: 130
Study: 20884122

Group type: EXPERIMENTAL
Intervention: Praziquantel 40 mg/kg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Praziquantel 75 mg/kg
Number of subjects: 21
Study: 18172274

Group type: EXPERIMENTAL
Intervention: Fenretinide (200 mg/day orally for 12 months)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Fenretinide
Number of subjects: 149
Study: 16983834

Group type: EXPERIMENTAL
Intervention: Argon Beam Coagulation (ABC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Monopolar electrocoagulation
Number of subjects: 50
Study: 14524649

Group type: EXPERIMENTAL
Intervention: Collaborative care model with clinical pharmacists
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125
Study: 10836286

Group type: EXPERIMENTAL
Intervention: Venlafaxine 37.5 mg in the morning and evening, increased to 75 mg twice daily after 4 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Paroxetine 20 mg in the morning and placebo in the evening, increased to 20 mg twice daily after 4 weeks
Number of subjects: 84
Study: 8925479

Group type: EXPERIMENTAL
Intervention: Argon green laser (AGL) treatment
Number of subjects: 191

Group type: COMPARATOR
Intervention: Krypton red laser (KRL) treatment
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Both AGL and KRL treatments
Number of subjects: 191
Study: 1806404

Group type: EXPERIMENTAL
Intervention: H1 antagonist (chlorpheniramine 4 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6761370

Group type: EXPERIMENTAL
Intervention: 50 mg hydrochlorothiazide orally daily
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 60 mg slow-release furosemide orally daily
Number of subjects: 38
Study: 31307381

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 10591

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 10591
Study: 28742614

Group type: EXPERIMENTAL
Intervention: OC + SOCK
Number of subjects: 41

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: OC
Number of subjects: 41
Study: 27842565

Group type: COMPARATOR
Intervention: Standard care (parenteral morphine at 0.1 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard care plus a landmark-guided fascia iliaca compartment block (FICB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard care plus an US-guided femoral nerve block
Number of subjects: 0
Study: 24113851

Group type: COMPARATOR
Intervention: No AF group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paroxysmal AF
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Persistent AF
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Long-standing AF
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Persistent and long-standing AF
Number of subjects: 80
Study: 22515638

Group type: EXPERIMENTAL
Intervention: Health Utilities Index Mark II (HUI2)
Number of subjects: 2053

Group type: EXPERIMENTAL
Intervention: Health Utilities Index Mark III (HUI3)
Number of subjects: 2053

Group type: EXPERIMENTAL
Intervention: Feeling Thermometer (FT)
Number of subjects: 2053

Group type: EXPERIMENTAL
Intervention: Health Utilities Index Mark II (HUI2) and Health Utilities Index Mark III (HUI3)
Number of subjects: 2053
Study: 21207918

Group type: EXPERIMENTAL
Intervention: 2.5% NovaMin
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 7.5% NovaMin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 17763365

Group type: EXPERIMENTAL
Intervention: Early cardioversion after therapeutic anticoagulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation prior to cardioversion
Number of subjects: 0
Study: 16166415

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 731
Study: 12897994

Group type: EXPERIMENTAL
Intervention: omega-3 lipid emulsion
Number of subjects: 10

Group type: COMPARATOR
Intervention: omega-6 lipid emulsion
Number of subjects: 10
Study: 10539780

Group type: EXPERIMENTAL
Intervention: Nutrient-dense foods (enriched with micronutrients, 25-100% of RDA)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Exercise (skill training including strength, endurance, coordination, and flexibility)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Both nutrient-dense foods and exercise
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 145
Study: 8837185

Group type: EXPERIMENTAL
Intervention: Single-injection femoral 3-in-1 nerve block with 20 mL 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Continuous femoral 3-in-1 nerve block
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 33
Study: 1360803

Group type: EXPERIMENTAL
Intervention: Alfentanil 5 micrograms/kg bolus followed by normal saline infusion
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Esmolol 500 micrograms/kg bolus followed by esmolol 300 micrograms/kg/min infusion
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normal saline bolus followed by normal saline infusion
Number of subjects: 42
Study: 6386007

Group type: EXPERIMENTAL
Intervention: Nifedipine (NI) 5, 10, 20 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Acebutolol (AC) 200 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of NI (10 mg three times a day) and AC (200 mg three times a day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30515646

Group type: EXPERIMENTAL
Intervention: Upper group (UG) patients who spared the glottic larynx
Number of subjects: 71

Group type: COMPARATOR
Intervention: Lower group (LG) patients who did not spare the glottic larynx
Number of subjects: 71
Study: 30201602

Group type: EXPERIMENTAL
Intervention: Mental Health eClinic (MHeC) online assessment
Number of subjects: 204

Group type: COMPARATOR
Intervention: Traditional face-to-face assessment by a Youth Access Clinician
Number of subjects: 204
Study: 26825264

Group type: EXPERIMENTAL
Intervention: Highly responsive virtual human (avatar) programmed to be highly responsive (high contingency)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-responsive virtual human (avatar) programmed to be not responsive (low contingency)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both conditions (high and low contingency)
Number of subjects: 61
Study: 24876916

Group type: EXPERIMENTAL
Intervention: Lutein supplementation
Number of subjects: 150
Study: 23338258

Group type: EXPERIMENTAL
Intervention: Electric toothbrushing after exposure to acid fruit juices
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sonic toothbrushing after exposure to acid fruit juices
Number of subjects: 50

Group type: COMPARATOR
Intervention: Acid fruit juices (kiwifruit, starfruit, green apple, pineapple, acerolla)
Number of subjects: 50
Study: 20496852

Group type: EXPERIMENTAL
Intervention: Modified fluoride toothpaste technique (2 cm toothpaste, brush for 2 min, swish for 30 sec, no rinsing or eating/drinking for 2 hr)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Regular fluoride toothpaste (no additional instructions)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Modified fluoride toothpaste technique
Number of subjects: 175

Group type: COMPARATOR
Intervention: Regular fluoride toothpaste
Number of subjects: 175
Study: 18572319

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (Healthy controls)
Number of subjects: 36
Study: 15752374

Group type: EXPERIMENTAL
Intervention: 2 mg single-dose pitavastatin in Child-Pugh grade A
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 mg single-dose pitavastatin in Child-Pugh grade B
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 12
Study: 12450962

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dose increase
Number of subjects: 10
Study: 11196123

Group type: EXPERIMENTAL
Intervention: CRVO
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: BRVO
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control
Number of subjects: 384
Study: 7933492

Group type: EXPERIMENTAL
Intervention: Group I: ETCO2 40 mmHg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group II: ETCO2 30 mmHg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group III: ETCO2 20 mmHg (hyperventilated group)
Number of subjects: 15
Study: 2971506

Group type: EXPERIMENTAL
Intervention: Combined oral pills, progestogen‐only oral pills, vaginal ring
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Depot‐medroxyprogesterone acetate (DMPA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 5
Study: 29978186

Group type: EXPERIMENTAL
Intervention: Cilioretinal artery present
Number of subjects: 3647